Company Name or Ticker Symbol
Search for other Categories
Nemus Bioscience, Inc.  (NMUS)
Other Ticker:  
    Sector  Conglomerates    Industry Diversified


Deficit Bigger Than a Year Ago but Revenues Unchanged

decrease font size NEWS BETA Increase font size

Nemus Bioscience, Inc announced first quarter 2017 operating loss of $-1.380153 millions

For the first quarter 2017 Nemus Bioscience, Inc losses widen of $-0.09 per share compare to $-0.08 a year ago and from $-0.09 per share from the previous quarter.

Sales remained unchanged to $0 millions from $0 millions in the same quarter a year ago and sequentially from $0 millions.

In the first quarter 2017 Nemus Bioscience, Inc reported net loss of $-1 million, instead of deficit of $-2 millions in the same quarter a year ago.
Other NMUS's Earnings Reports

Nemus Bioscience reported forth quarter 2016 earnings

Nemus Bioscience reported third quarter 2016 earnings

Nemus Bioscience reported second quarter 2016 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com